Kelly L. Galen, PharmD, BCPS

Size: px

Start display at page:

Download "Kelly L. Galen, PharmD, BCPS"

Norah Shelton
6 years ago
Views:

1 Kelly L. Galen, PharmD, BCPS CONTACT INFORMATION University of Illinois College of Pharmacy Department of Pharmacy Practice 833 S. Wood St; Suite 164, MC 886 Chicago IL Office Phone: x 1 Fax: Cell Phone: klg@uic.edu klgalen@gmail.com PROFESSIONAL APPOINTMENTS Clinical Pharmacist July Solid Organ Transplant Gastroenterology-Inflammatory Bowel Disease University of Illinois Hospital and Health Sciences System Supervisor: John Garofalo, PharmD, BCPS Clinical Assistant Professor Department of Pharmacy Practice University of Illinois at Chicago, College of Pharmacy Department of Pharmacy Practice Head: Janet P. Engle, PharmD, FAPhA July EDUCATION University of Missouri - Kansas City College of Pharmacy August May 2012 Doctor of Pharmacy Magna Cum Laude POST-DOCTORAL TRAINING ASHP Accredited Solid Organ Transplant Residency, PGY2 July June 2014 University of Illinois at Chicago Director: James Thielke, PharmD ASHP Accredited Pharmacy Practice Residency, PGY1 June June 2013 Saint Luke s Hospital of Kansas City Director: Mark Woods, PharmD, FASHP, BCPS Resident Teaching Certificate June June 2013 University of Missouri-Kansas City Director: Heather Pace, PharmD Cirriculum Vitae Page 1 of 5

2 PROFESSIONAL LISCENSURE and CERTIFICATION State of Missouri, Registered Pharmacist: License Number: June 2012 State of Illinois, Registered Pharmacist: License Number July 2013 Board Certified Pharmacotherapy Specialist (BCPS) November 2013 Collaborative Institutional Training Initiative Certification September 2012 APhA Pharmacy-Based Immunization Delivery February 2010 HONORS and AWARDS Young Innovator Award-AST Cutting Edge of Transplantation February 2014 MSHP Original Research 1 st place April 2013 Rho Chi Pharmacy Academic Honor Society March present NON-FUNDED ONGOING RESEARCH Renal Function after Conversion to mtor-inhibitor in Liver Transplant Recipients, PGY1 research project mentor A Retrospective Review of Solid Organ Transplant Preservation Fluid Cultures at University of Illinois Medical Center at Chicago A comparison of Alemtuzumab and Antithymocyte Globulin Induction in High- Risk, Non-Sensitized Renal Transplant Recipients PGY2 prospective research project; Principal investigator (July June 2015); Coinvestigator (present) 2014 present Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (Belatacept)-based Immunosuppression, Protocol Number: IM A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy Study Number: C Cirriculum Vitae Page 2 of 5

3 Sponsor: A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients Astellas Pharma US, Inc. A randomized, open label, multicenter study of a belatacept-based early glucocorticoid withdrawal regimen with alemtuzumab or rabbit antithymocyte globulin induction compared to a tacrolimus-based early glucocorticoid withdrawal regimen with rabbit antithymocyte globulin induction in renal transplantation Levofloxacin Prophylaxis for BK Viremia in Kidney Transplant Recipients PUBLICATION Galen KL, Lurk KM, Smith AJ. Transdermal Nicotine Replacement Therapy Safety in Patients with Cardiovascular Disease. Hosp Pharm 2011; 46 (10): POSTER ABSTRACTS Nam H, Perni N, Galen K, Campara M, Garcia-Roca R, Yeldandi Y. Significance of Preservation Fluid Cultures in Solid Organ Transplant. (D#127) Presented at the 2016 American Transplant Congress, Boston MA, June Liu M, Galen K, Guzman G, Jeon H, Aloman C. Recipient Risk Factors for Acute Cellular Rejection After Orthotopic Liver Transplant Patients with Average MELD More Than 25. (#1266). Presented at the 2015 American Association for the Study of Liver Diseases, San Francisco, CA. November Janusek M, Patel S, Galen K, West-Thielke P, Benedetti E, Thielke J. A Comparison of Alemtuzumab and Antihymocyte Globulin Induction in High-Risk, Non-Sensitized African American Renal Transplant Recipients. Am J Transplant 2015; 15s3 (#864). Presented at the 2015 American Transplant Congress, Philadelphia, PA. May Galen K, West-Thielke P, Huber M, Hetterman E, Benken J, Campara M, Johnsen M, Satterlee M, Theilke J. A Prospective, Randomized Study of Levofloxacin Prophylaxis for BK Viremia in Kidney Transplant Recipients. Am J Transplant 2014; 14s3:554 (#B1016). Presented at the 2014 World Transplant Congress, San Francisco, CA. July Galen K, West-Thielke P, Huber M, Hetterman E, Benken J, Campara M, Johnsen M, Satterlee M, Theilke J. A Prospective, Randomized Study of Levofloxacin Prophylaxis for BK Viremia in Kidney Transplant Recipients. Presented at the American Society of Transplantation-Cutting Edge of Transplantation, Chandler, AZ. February 2014 Cirriculum Vitae Page 3 of 5

4 PROFESSIONAL MEMBERSHIP and LEADERSHIP ACTIVITIES Cornerstones Inflammatory Bowel Disease Roundtable August 2016 Mastering Clinical Challenges and Emerging Therapies in IBD: July 2016 Individualizing our Approach to IBD Symposium Illinois Transplant Pharmacists Association (ITPA) American Transplant Congress 2017 Planning Committee-Member American Society of Transplantation Mentor Committee: Member Transplant Pharmacy Community of Practice: Member Trainee and Young Faculty Community of Practice: Member American College of Clinical Pharmacy Solid Organ Transplant PRN member Rho Chi Pharmacy Academic Honor Society present present present present present present INVITED PRESENTATIONS Galen, K. Hepatitis C Virus is Solid Organ Transplant May 2014 ACPE accredited CE program (1 hour). University of Illinois Chicago College of Pharmacy Galen, K. Acute Myocardial Infarction Readmission Rates May 2013 Platform Presentation. Midwest Pharmacy Residents Conference, Omaha, NE TEACHING AND PRECEPTING EXPERIENCE International Pharmacy Mentor September 2015 present APPE Primary Preceptor Ambulatory Care - Transplant and Gastroenterology ASHP Accredited Pharmacy Practice Residency Preceptor ASHP Accredited Specialty Residency/ Solid Organ Transplant Preceptor Recitation Facilitator; Calcium and Phosphorus Homeostasis Principles of Drug Action and Therapeutics PHAR 407 June July 2014 present July Spring present Cirriculum Vitae Page 4 of 5

5 Mock Patient Interview Evaluator Experiential III-IPPE Fall Recitation Facilitator; Transplant Specialty Spring 2014 Principles of Drug Action and Therapeutics PHAR 407 DIDATIC LECTURES Galen, K. Calcium and Phosphorus Homeostasis, 3 hours Spring present Principles of Drug Action and Therapeutics VII, PHAR407 Galen, K. Post-transplant acute management of kidney recipients, 1 hour Spring Galen, K. Immunosuppression: Maintenance and Rejection Spring Spring 2015 Controversies, 2 hours Galen, K. Pharmacokinetics of Immunosuppressants, 2 hours Spring 2014 Applied Pharmacokinetics, PMPR440 Galen, K. Immunosuppression Pharmacokinetics, 1 hour Spring 2014 Cirriculum Vitae Page 5 of 5

OBJECTIVES. Phases of Transplantation and Immunosuppression

OBJECTIVES. Phases of Transplantation and Immunosuppression Transplant and Immunosuppression: Texas Transplant Center April 29, 2017 Regina L. Ramirez, Pharm.D., BCPS PGY1 Pharmacy Residency Program Director Clinical Practice Specialist Solid Organ Transplant and